Federal regulators have concluded that the risk of potential complications is low.
The US Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have again authorized the use of Johnson & Johnson’s COVID-19 vaccine.
The use of this vaccine was suspended after six women who received the vaccine developed blood clots. About 7 million people were vaccinated with the Johnson & Johnson vaccine in the United States.
The FDA said that an analysis of the available data demonstrates that the possible benefits of using this vaccine far outweigh the risks for people aged 18 and older and that the risk of blood clots is very low.
Vaccinations with this vaccine will be started immediately.